A Cambridgeshire company is working on a new way to make medicines in space.
The UK Space Agency (UKSA) announced BiologIC Technologies will share a £65m fund to develop new technologies which will be tested inside the International Space Station (ISS).
Microgravity makes some health research, such as studying age-related diseases, and potentially growing human organs for transplant, easier in space than on earth.
BiologIC Technologies chief executive, Richard Vellacott, says: “It’s a privilege to help the UK lead the way.”
Governments and entrepreneurs around the world are once again spending huge sums of money on space, but it is not about reaching other planets anymore, it is about enabling humans to live on them.
Company wins funding to make medicine in space
